Perampanel: first-in-class AED for partial-onset seizures

Perampanel (Fycompa), an AMPA receptor antagonist, is licensed as adjunctive treatment of partial-onset seizures. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Andrew Kelso discusses its place in the treatment of epilepsy.

Perampanel first in class AED for partial onset seizures

Add yours ↓
Web design and marketing agency Leamington Spa